period of embryonic immune system development in domestic chickens (Gallus gallus).
birds. We tested this by manipulating aromatase activity during development by exposing immune tissue development. We tested two contrasting hypotheses (Fig. 1) . The first response to embryonic testosterone administration is due (at least in part) to 1 0 6 aromatization of androgens to estrogens. Under this hypothesis, we predicted that 1 0 7 aromatase inhibition in ovo would result in elevated immune activity relative to controls.
0 8
The second hypothesis (H2) asserts that aromatization is not involved in regulating 1 0 9 immune activity of developing birds. Therefore, under this hypothesis we predicted that immunosuppressive and inhibition of aromatase causes a buildup of testosterone due to 1 1 3 lack of negative feedback in the hypothalamus. Note that our conceptual framework is 1 1 4 based on studies in chickens which show that testosterone either inhibits or has no effect 1 1 5 on immune function, rather that enhancing it. e  x  2  7  1  8  R  (  A  T  T  G  A  A  A  T  G  A  T  C  C  A  G  T  G  C  T  T  G  ) (mean±SEM). Inclusion of brooder as a random effect did not improve model fit (σ 2 < 3 2 3 0.0001±0.00), so a GLM without any random effect was used for model selection. The best-fit model was the null model, but 3 other models were similarly well fit to the data as the null (i.e., within 2 AICc). These models individually included fixed effects of phytohemagglutinin (PHA) status (whether or not the bird was injected with PHA),
treatment, or sex. However, in model averaging, none of the effects of these factors were affect size-corrected bursal mass. Inclusion of brooder as a random effect did improve model fit (σ 2 < 0.0001±0.00), so model selection was conducted using an LME with this random effect retained. The 3 3 3 4
best-fit models contained sex, treatment, and their interaction (Table 2 ). Model averaged
effects reveal that, overall, males tended to have lower size-corrected thymic mass (β = -
0.001, p = 0.083), and that Fadrozole-treated birds tended to have higher size-corrected
thymic mass (β = 0.001, p = 0.056; Fig. 3 ). The interaction term was not significant. 0.00±0.00), so model selection was conducted using an LME with only individual
identity as a random effect (σ 2 = 0.00±0.00; retained because testosterone was measured 3 5 1 twice in each individual). The 3 best fit models retained age, body mass, and sex; best-fit models indicate that testosterone was higher in males than females (β = 0.856, p < testosterone concentrations are excluded from the analyses; however, the decline with age 3 5 7
is dampened and no longer significant (β = -0.026, p = 0.186). Thus, treatment with
Fadrozole did not affect circulating testosterone concentrations in 3-or 18-day old birds 3 5 9 (Fig. 4) . 3.6 IgY-Bursa Relationship
The inclusion of brooder as a random effect (σ 2 = 0.002±0.04) did not improve 3 6 9 model fit, so model selection was conducted with a GLM. The 3 best-fit models retained
treatment, size-corrected bursal mass, sex, a sex by bursal mass interaction, a treatment by bursa interaction, and a sex by treatment interaction effect (Table 3) . Model averaging
revealed both a sex-dependent (β = -104.5, p < 0.001) and a treatment-dependent
relationship between bursal mass and IgY (β = 67.14, p = 0.027). Within females,
Fadrozole exposure caused the positive relationship between bursal mass and day 18 IgY to increase in slope, which led to elevated IgY levels for a given bursal mass relative to
controls. Conversely, control males exhibited a negative correlation between bursal mass 3 7 7
and day 18 IgY, with Fadrozole treatment tending to dampen the relationship (Fig. 5 ). Inclusion of brooder as a random effect did improve model fit (σ 2 < 0.0001±0.00),
so model selection was conducted using a LME with this random effect. The 5 best-fit 3 8 9 models retained log-testosterone, sex, treatment, a sex by treatment interaction effect, and 3 9 0 a testosterone by treatment interaction effect (Table 4) . Model averaging indicated that
the interaction of log-testosterone by treatment and sex by treatment were both 3 9 2 marginally significant. The majority of females had undetectable testosterone levels at day 18, precluding analysis of the relationship between testosterone and thymic mass. In control males, there was a negative relationship between plasma testosterone and size- relationship between plasma testosterone and size-corrected thymic mass (Fig. 6 ). The inclusion of brooder as a random effect (σ 2 = 0.00±0.00) did not improve model, but 3 other models were similarly well-fit to the data. These 3 models retained sex 18 thymic mass, and increased day 18 IgY levels for a given bursal mass in females.
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While thymic mass in control males was negatively correlated with plasma testosterone
titers, as expected (Mase and Oishi, 1991) , the opposite was true of Fadrozole treated
birds, with higher plasma testosterone titers being associated with larger thymuses.
2 8
Because aromatization was necessary to induce thymic atrophy, our results strongly
support hypothesis #1 ( Fig. 1) , which asserts that conversion of T to estradiol during Fadrozole exposure tended to increase day 18 IgY levels for a given bursal mass 4 3 7
in females (Fig. 5) . This relationship suggests that estradiol inhibits bursal IgY indirectly through some other means) or by upregulation of IgY catabolism or excretion.
5 7
We are not able to distinguish between these possibilities in this study, but to our
knowledge, this is the first study to demonstrate that inhibition of aromatase alters uptake maturing immune system and in susceptibility to early infection. Fadrozole exposure tended to increase body mass-corrected thymic mass of 18 4 6 9 day old chicks (by about 15% in females; Fig. 3 ), suggesting that endogenous estradiol
inhibits thymic growth for a given body size. Our results corroborate previous studies in aromatase inhibition did not result in a corresponding increase in PHA swelling response.
However, the mechanics of PHA-induced inflammation generate a complex relationship of correlation between thymic mass and PHA response may not be surprising in the wake
of the recent reevaluation of the PHA challenge and its implications (Hasselquist and
Nilsson, 2012; Kennedy and Nager, 2006; Martin et al., 2006; Tella et al., 2008) . 4.6 Plasma testosterone
The lack of differences among treatments in day 3 and day 18 plasma testosterone 5 0 1 levels suggests that the changes observed were mediated by organizational effects and estradiol levels were not quantified, it is not possible to definitively identify whether given the mechanism of negative feedback for testosterone, because negative regulation
of testosterone production is mediated in the hypothalamus by locally-aromatized
estradiol, rather than testosterone itself. Therefore, by inhibiting estradiol production, we 5 1 2 also inherently reduce negative feedback on testosterone manufacture in the that the elevated immune function in chicks from Fadrozole treated eggs was driven by
an increase in developmental testosterone exposure, since studies that manipulate in ovo
testosterone exposure in chickens consistently report inhibition of immune function Glick, 1956 Glick, , 1961 Hillgarth and Wingfield, 1997; Hirota et al., 1976 ; Navara and
Mendonca , 2008; Norton and Wira, 1977) . In addition, studies in rats provide precedent
for a direct immumodulatory role of estradiol.
In one experiment, aging and young adult rats were orchidectomized and
surgically implanted with testosterone or testosterone and the aromatase inhibitor 1,4,6-
androstatriene-3,17-dione (ATD). The thymus naturally degenerates with age in rats, and
the effect was accelerated in the testosterone only treatment. However, the testosterone + aromatase inhibitor treatment caused a restoration of the thymus, and even enlarged the gland in young intact rats, indicating that testosterone-dependent thymic degeneration is 5 2 6 contingent on aromatization (Greenstein et al., 1992) . Thus, our results, in conjunction
with previous studies, strongly implicate aromatization as a pathway through which understanding of testosterone's role in avian immunity is incomplete. Manipulation of
testosterone either during development or in adulthood is a standard method for studying
the role of androgens, yet without accounting for aromatization, it is impossible to 5 3 2 distinguish between the effects of testosterone and those of one of its active metabolites, In the present study, we demonstrate that developmental aromatase inhibition observation that exposure to both testosterone, and its downstream metabolite estradiol,
generally results in suppression of immune metrics, our results suggest that aromatization
plays a crucial role in testosterone-mediated immunosuppression.
4 1
Experimental ablation alone is not sufficient to fully elucidate a hormone's role
in a physiological process (Zera et al., 2007) , and a more integrative investigation, and fitness studies, will be needed to disentangle the relative contribution of estradiol to
immune function. However, the present study provides valuable groundwork towards this
end. Considering the paucity of data regarding estradiol-mediated immunosuppression in
the context of physiological and behavioral ecology relative to its precursor, testosterone, investigation into the potential role of aromatization. from Bucknell University to J.S. 
